The only significant drop was SBTX:SkinBioTherapeutics which fell 5%. It wasn't even allowed to get to the normal 20p resistance level this time, peaking at 18.5p before falling back to 16.5p bid price. The pricing confirms that you can't believe a word of the buy/sell stats as it showed practically all buys for the whole week and the price still dropped 5%.
IES:Invinity Energy had a surprising spurt this week, with many people making big profits as it rose 50% from the recent low. However, for me it was a 6% rise on my purchase price and it's still 88% down. I'm pretty happy though, as I'd written this off as bankrupt when RED:RedT Energy ran out of cash. The reverse takeover may mean I get to salvage something.
CAML:Central Asia Metals has had a miserable time lately, not helped by low metal prices and suspending the dividend. This was always my guaranteed "in the black" share that I'm holding for the long term, so it has been a shock to see it fall so far. There was a 6% recovery this week, so we are only 26% down now. The problem is, I need the recovery to stall until Legal & General get their arse into gear and complete my pension transfer. If it had come through after the usual 10 days I could have bought CAML at 132p, but now I'll have to pay 142p. Thanks a bunch Legal & General!
TRMR:Tremor were the 3rd share that rose by 6% this week. Buying these was the biggest mistake in my sorry trading account history. They are still 55% down despite the rise.
JLP:Jubilee Metals continue to frustrate, as they manage to shoot themselves in the foot every time the price looks like recovering. This time they announced that the fine chrome plant is to be dismantled and moved from DCM to an operation that's generating a lot more chrome tailings. That's a sensible thing to do, but it caused the price to drop to what it was a few weeks ago. I did take advantage of the drop to spend my £500 SIPP tax rebate on some of these. Fortunately there was a rally at the end of the week, so my ISA finished 8% up and my trading account climbed by 13%.
Share of the week was OPTI:Optibiotix, which despite causing me much misery on Friday as I watched £7,700 wiped off my weekly gain, still climbed 10p which is a healthy 15% and was responsible for £11,000 of the £11,768 rise this week.
Good news, but we have hit the point that has triggered a big dip 3 times over the last 6 months. Funnily it just happens to be the OPTI:Optibiotix trading resistance point. Can we finally break through it this time, or are we about to see another 6 weeks of misery?
If I can get above -£20k then the trend line should reverse in about 14 weeks time.
The ISA and share portfolios look like this
Weekly Change | |||
Cash | £7.98 | +£0 | |
Portfolio cost | £59,827.79 | +£0 | |
Portfolio sell value (bid price-commission) | £46,554.76 | (-22.2%) | +£6.631.32 |
Potential profits | £0 | +£0 | |
Yr 5 Dividends | £0.63 | +£0 | |
Yr 5 Profit from sales | £-167.28 | +£0 | |
Yr 5 Average monthly cash profit | -£20.68 | (-0.4%) | +£0.50 |
Total Dividends | £1,342.93 | +£0 | |
Total Profit from sales | £20,224.13 | +£0 | |
Average monthly cash profit | £369.92 | (7.4%) | -£1.49 |
(Sold stocks profit + Dividends - Fees / Months) | |||
Performance/Injection | 11.3% | -0.1% | |
Compound performance | 54% | +0% |
It's great to see a £6,631 improvement. If the market had closed at Friday lunchtime it would have been a £10,600 rise and I would have been able to report £3,525 potential profits, but as the traders took their toll I ended up with no potential profit and OPTI:Optibiotix still down, but only by 1%. That's still £600 though. Not much activity aside from that. I should clobber myself with a brick for being such an idiot and moping about because of the Friday fall - this was still one of my best ever weeks and I should be celebrating!
Healthy bounce
This account has the most difficult trend line to reverse I think.
The SIPP looks like this after week 234
Weekly Change | ||||
Cash | £30.01 | +£7.51 | ||
Portfolio cost | £49,668.66 | +£492.49 | ||
Portfolio sell value (bid price - commission) |
£40,766.55 | (-17.9%) | +£5,005.66 | |
Potential profits | £239.14 | -£142.49 | ||
Yr 5 Dividends | £0 | +£0 | ||
Yr 5 Interest | £0.03 | +£0 | ||
Yr 5 Profit from sales | £0 | +£0 | ||
Yr 5 Average monthly cash profit | -£12.60 | (-0.3%) | +£0.55 | |
Total Dividends | £1,899.24 | +£0 | ||
Total Interest | £0.20 | +£0 | ||
Total Profit from sales | £12,549.10 | +£0 | ||
Average monthly cash profit | £257.84 | (6.2%) | -£1.11 | |
(Sold stocks profit + Dividends - Fees / Months) | ||||
Performance/Injection | 9.7% | -0.1% | ||
Compound performance | 44% | +0% |
A flurry of excitement as my £500 tax rebate arrived. I was going to combine it with my £2,800 transfer, but there's no sign of that arriving soon so I took advantage of the dip in JLP:Jubilee Metals and bought 14,485 shares at 3.3175p costing £492.49. That left the £7.51 added to the cash to keep me at the suggested minimum of £30. The new JLP shares are down 7% due to the wide spread and commission, but I'm hoping this will be a short term investment as I can see them hitting 5p quite soon. That will give a 45% profit so I can further my magic formula plans.
Similar story to the ISA, with a fantastic £5,005 increase, but SBTX:SkinBioTherapeutics big drop cost me all last weeks gains in potential profit as it fell £142. I could do with a quick profit from JLP to fix my struggling performance stats.
Halfway between injection and cost - I'm feeling it won't get back into profit before the previous profitable weeks disappear of the left side of the chart.
Less than £10k deficit to make up - that starts to give me hope.
The trading account looks like this after week 200
Weekly Change | |||
Cash | £0.09 | +£0 | |
Portfolio cost | £2,490.21 | +£0 | |
Portfolio sell value (bid price - commission) | £1,578.54 | (-36.6%) | +£131.19 |
Potential profits | £87.64 | +£79.22 | |
Year 4 Dividends | £13.20 | +£0 | |
Year 4 Profit | £120.77 | +£0 | |
Yr 4 Average monthly cash profit | £13.19 | (6.4%) | -£0.31 |
Dividends | £47.92 | +£0 | |
Profit from sales | £56.48 | +£0 | |
Average monthly cash profit | £2.26 | (1.1%) | -£0.01 |
(Sold stocks profit + Dividends - Fees / Months) | |||
Performance/Injection | 1.2% | +0% | |
Compound performance | 5% | +0% |
A great week, with all shares climbing a little. JLP:Jubilee Metals extended potential profits by £79 to £87 and if this is a trading account I really should be thinking about taking the profits, but I have a feeling there's quite a lot more to come over the next few weeks.
Aaargh! See - I'm a rubbish trader - I'm thinking long term when I have a stack in my ISA for that - I'm meant to be following momentum and there is a risk this will drift on no news for the next few weeks. I should be planning to buy and sell within the same week in this account.
I should sell it next week whatever happens and get my 14% profit. I forgot until I checked my spreadsheet, that I initially had 9,120 JLP shares in this account but sold them at a £84 loss in order to move them to my ISA. I should have known then that I wasn't cut out for trading! So I'm only £3 up if you balance the 2 out. With that in mind, maybe I should let it go a teensy bit higher before selling.
Nice to see last week's blip removed
That trend line could be flat in a few weeks time. It would be great to have one account pointing in the right direction.
Last week the virtual magic formula account was down 21.17% and this week it's only down 18.36%, so an improvement of 2.81%. Top performer is still PLUS:Plus 500 at 58% up, with IGG:IG Group still up 15%. What really, really hacks me off is that the next best performer is FXPO:Ferrexpo up 10%, which was my number one target if Legal & General weren't so utterly useless. It's so frustrating that they are denying me a rare chance to buy a long term holding at a great price. Absolutely gutted.
It's a bank holiday on Monday so a short week next week. It will be a massive test for OPTI:Optibiotix to see if we can beat the traders and break out of the 70p resistance.
No comments:
Post a Comment